Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mouton

Showing results (101-110 of 392) with videos related to

Pageof 40
Sort By:
Antimicrobial Agents and Chemotherapy|May 23, 2002
Efficacy of antifungal therapy in a nonneutropenic murine model of zygomycosisEric Dannaoui, Johan W Mouton, Jacques F G M Meis, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 5, 2017
High interindividual variability in urinary fosfomycin concentrations in healthy female volunteersR A Wijma, B C P Koch, T van Gelder, et al.
BMC Microbiology|September 28, 2013
A structural comparison of lipopolysaccharide biosynthesis loci of Legionella pneumophila serogroup 1 strainsMarkus Petzold, Alexander Thürmer, Susan Menzel, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 21, 2016
Nitrofurantoin's efficacy and safety as prophylaxis for urinary tract infections: a systematic review of the literature and meta-analysis of controlled trialsA E Muller, E M Verhaegh, S Harbarth, et al.
Antimicrobial Agents and Chemotherapy|November 19, 2002
Effect of a single percutaneous abscess drainage puncture and imipenem therapy, alone or in combination, in treatment of mixed-infection abscesses in miceLorna E T Stearne, Steven L Buijk, Johan W Mouton, et al.
The Journal of Antimicrobial Chemotherapy|August 6, 2016
Dose optimization of voriconazole/anidulafungin combination against Aspergillus fumigatus using an in vitro pharmacokinetic/pharmacodynamic model and response surface analysis: clinical implications for azole-resistant aspergillosisMaria Siopi, Nikolaos Siafakas, Sophia Vourli, et al.
Antimicrobial Agents and Chemotherapy|August 3, 2016
Intra- and Interlaboratory Agreement in Assessing the In Vitro Activity of Micafungin against Common and Rare Candida Species with the EUCAST, CLSI, and Etest MethodsJ Meletiadis, E Geertsen, I Curfs-Breuker, et al.
Diagnostic Microbiology and Infectious Disease|September 23, 2011
In vitro activity of isavuconazole against 208 Aspergillus flavus isolates in comparison with 7 other antifungal agents: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility TestingShivaprakash M Rudramurthy, Arunaloke Chakrabarti, Erik Geertsen, et al.
Mycoses|April 27, 2011
In vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugsM R Shivaprakash, Erik Geertsen, Arunaloke Chakrabarti, et al.
Antimicrobial Agents and Chemotherapy|July 25, 2007
Effect of dosing and dosing frequency on the efficacy of ceftizoxime and the emergence of ceftizoxime resistance during the early development of murine abscesses caused by Bacteroides fragilis and Enterobacter cloacae mixed infectionLorna E T Stearne, Wil H F Goessens, Johan W Mouton, et al.
Pageof 40

Showing results (101-110 of 392) with videos related to

Sort By:
Pageof 40
Antimicrobial Agents and Chemotherapy|May 23, 2002
Efficacy of antifungal therapy in a nonneutropenic murine model of zygomycosisEric Dannaoui, Johan W Mouton, Jacques F G M Meis, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 5, 2017
High interindividual variability in urinary fosfomycin concentrations in healthy female volunteersR A Wijma, B C P Koch, T van Gelder, et al.
BMC Microbiology|September 28, 2013
A structural comparison of lipopolysaccharide biosynthesis loci of Legionella pneumophila serogroup 1 strainsMarkus Petzold, Alexander Thürmer, Susan Menzel, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 21, 2016
Nitrofurantoin's efficacy and safety as prophylaxis for urinary tract infections: a systematic review of the literature and meta-analysis of controlled trialsA E Muller, E M Verhaegh, S Harbarth, et al.
Antimicrobial Agents and Chemotherapy|November 19, 2002
Effect of a single percutaneous abscess drainage puncture and imipenem therapy, alone or in combination, in treatment of mixed-infection abscesses in miceLorna E T Stearne, Steven L Buijk, Johan W Mouton, et al.
The Journal of Antimicrobial Chemotherapy|August 6, 2016
Dose optimization of voriconazole/anidulafungin combination against Aspergillus fumigatus using an in vitro pharmacokinetic/pharmacodynamic model and response surface analysis: clinical implications for azole-resistant aspergillosisMaria Siopi, Nikolaos Siafakas, Sophia Vourli, et al.
Antimicrobial Agents and Chemotherapy|August 3, 2016
Intra- and Interlaboratory Agreement in Assessing the In Vitro Activity of Micafungin against Common and Rare Candida Species with the EUCAST, CLSI, and Etest MethodsJ Meletiadis, E Geertsen, I Curfs-Breuker, et al.
Diagnostic Microbiology and Infectious Disease|September 23, 2011
In vitro activity of isavuconazole against 208 Aspergillus flavus isolates in comparison with 7 other antifungal agents: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility TestingShivaprakash M Rudramurthy, Arunaloke Chakrabarti, Erik Geertsen, et al.
Mycoses|April 27, 2011
In vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugsM R Shivaprakash, Erik Geertsen, Arunaloke Chakrabarti, et al.
Antimicrobial Agents and Chemotherapy|July 25, 2007
Effect of dosing and dosing frequency on the efficacy of ceftizoxime and the emergence of ceftizoxime resistance during the early development of murine abscesses caused by Bacteroides fragilis and Enterobacter cloacae mixed infectionLorna E T Stearne, Wil H F Goessens, Johan W Mouton, et al.
Pageof 40